Science Explorer Back to mapMap
Discussion
Researcher · CARE Hospitals · India

Anil Aribandi

Anil Aribandi publishes mostly in Hematology, Oncology and Genetics, on topics such as Acute Lymphoblastic Leukemia research, CAR-T cell therapy research and Chronic Lymphocytic Leukemia Research.

OpenAlex
World rank
#5,823,459
of 7,710,434 ranked researchers
Rank in India
#177,102
of 280,097
Works
29
Citations
54
Citations per work
1.9
h-index
3
i10-index 2Top 96% in Hematology
Anil Aribandi

What does Anil Aribandi research?

Anil Aribandi's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 15 works · 51.3% of their workMedicine: 15 works · 51.3% of their workHematology: 4 works · 13.2% of their workOncology: 3 works · 11.8% of their workGenetics: 3 works · 9.2% of their workPublic Health, Environmental and Occupational Health: 3 works · 9.2% of their workInfectious Diseases: 2 works · 7.9% of their workEverything else: 13 works · 43.4% of their workLife Sciences: 2 works · 5.3% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 5.3% of their workMolecular Biology: 2 works · 5.3% of their workTHEIR WORKAnil Aribandi29works
Life Sciences5%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1551.3%
  2. Everything else1343.4%
    1. Biochemistry, Genetics and Molecular Biology25.3%
  1. 1Hematology13% of their works
  2. 2Oncology12% of their works
  3. 3Genetics9% of their works
  4. 4Public Health, Environmental and Occupational Health9% of their works
  5. 5Infectious Diseases8% of their works
  6. 6Molecular Biology5% of their works

Research topics

Which keywords describe Anil Aribandi's research?

The keywords of their largest research topics: Prognostic Factors, Lymphoma, Rituximab, Acute Lymphoblastic Leukemia, Childhood Cancer, CAR T Cells, Chimeric Antigen Receptor and BCR-ABL.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors123 topics
  2. Lymphoma82 topics
  3. Rituximab72 topics
  4. Acute Lymphoblastic Leukemia61 topic
  5. Childhood Cancer61 topic
  6. CAR T Cells51 topic
  7. Chimeric Antigen Receptor51 topic
  8. BCR-ABL41 topic
  9. COVID-1941 topic
  10. Cancer41 topic
  11. Chronic Lymphocytic Leukemia41 topic
  12. Genomic Aberrations41 topic
  13. Imatinib41 topic
  14. Bone Marrow Biopsy31 topic
  15. Classification31 topic
  16. FDG PET/CT31 topic
  17. Molecular Profiling31 topic
  18. Cutaneous Lymphomas21 topic
  19. Mycosis Fungoides21 topic

Where does Anil Aribandi work?

Anil Aribandi's main affiliation in the publication record is CARE Hospitals, India.

How many publications and citations does Anil Aribandi have?

OpenAlex counts 29 works and 54 citations for Anil Aribandi, an h-index of 3, ranking #5,823,459 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anil Aribandi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.